Grant: Master's Award: Canada Graduate Scholarships
Université de Montréal
$17,500.00
Role of DUSP1 in the negative regulation of the innate immune antiviral response
EF 2014-15
Résumé
Respiratory Syncytial Virus (RSV) is the etiologic agent that causes the most pediatric respiratory infections. Only a very expensive prophylactic treatment is available. Development of novel therapies requires knowledge of RSV pathogenesis mechanisms. Airway epithelial cells (AEC), the first in contact with RSV, play a key role in the innate immune antiviral response through cytokines/chemokines secretion, such as interferons (IFNs), TNFa and RANTES. This response needs to be strictly regulated to avoid damages caused by an excessive cytokine production. Preliminary observation from our laboratory suggests a role of the dual specificity phosphatase 1 (DUSP1) in the inhibition IFNß expression that is regulated by the AP-1, NF-?B and IRF3 transcription factors. Our goal is to demonstrate that DUSP1 is a negative regulator of the innate immune signaling cascade(s) that regulates cytokines/chemokines expression during RSV infection in AEC. First, we will determine the role of DUSP1 in the resolution of the innate immune response through the analysis of the expression of a panel of RSV-induced antiviral/proinflammatory cytokines in AEC following DUSP1 overexpression or inhibition using dominant-negative or RNA interference strategy. Next, a detailed analysis of the mechanisms involved in DUSP-1-dependent regulation will be performed. In particular, we will characterize the role of DUSP1 in the regulation of the signaling cascades leading to AP-1, NF-?B and IRF3 activation. Activation of signaling proteins and promoter activities will be monitored after inhibition or overexpression of DUSP1. These studies will allow us to define DUSP1 as a potential therapeutic target to limit inflammation associated to RSV.
Programme
Master's Award: Canada Graduate Scholarships
Bénéficiaire
Emplacement
Quebec, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
331400
Name
Robitaille Alexa
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Role of DUSP1 in the negative regulation of the innate immune antiviral response
Programtype2
Studentship Programs
Orgnameinp2
Université de Montréal
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Antivirals; Cell Signaling; Cellular Defense; Immune System; Inflammation; Viral Infections
Abstract
Respiratory Syncytial Virus (RSV) is the etiologic agent that causes the most pediatric respiratory infections. Only a very expensive prophylactic treatment is available. Development of novel therapies requires knowledge of RSV pathogenesis mechanisms. Airway epithelial cells (AEC), the first in contact with RSV, play a key role in the innate immune antiviral response through cytokines/chemokines secretion, such as interferons (IFNs), TNFa and RANTES. This response needs to be strictly regulated to avoid damages caused by an excessive cytokine production. Preliminary observation from our laboratory suggests a role of the dual specificity phosphatase 1 (DUSP1) in the inhibition IFNß expression that is regulated by the AP-1, NF-?B and IRF3 transcription factors. Our goal is to demonstrate that DUSP1 is a negative regulator of the innate immune signaling cascade(s) that regulates cytokines/chemokines expression during RSV infection in AEC. First, we will determine the role of DUSP1 in the resolution of the innate immune response through the analysis of the expression of a panel of RSV-induced antiviral/proinflammatory cytokines in AEC following DUSP1 overexpression or inhibition using dominant-negative or RNA interference strategy. Next, a detailed analysis of the mechanisms involved in DUSP-1-dependent regulation will be performed. In particular, we will characterize the role of DUSP1 in the regulation of the signaling cascades leading to AP-1, NF-?B and IRF3 activation. Activation of signaling proteins and promoter activities will be monitored after inhibition or overexpression of DUSP1. These studies will allow us to define DUSP1 as a potential therapeutic target to limit inflammation associated to RSV.
Competitiondate
201412
Approvedterm2
1 yr 0 mth
Pinamesdelim
Robitaille, Alexa
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~